India's Pharmaceutical Exports

Country Profile

Angola

Angola is a growing market for Indian pharmaceuticals — $89.1M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 85% of shipments, with vaccines contributing $6.72M. The compound annual growth rate since FY2015 stands at 4.2%.

🇦🇴 $89.1M · 1.6× growth since FY2015 · 4.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$89.1M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.2%
CAGR FY2015→2026
85%
Medicines Share
5
Product Categories Supplied
Angola is a growing market for Indian pharmaceuticals — $89.1M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 85% of shipments, with vaccines contributing $6.72M. The compound annual growth rate since FY2015 stands at 4.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $75.7M (85.0%) Vaccines $6.72M (7.5%) Surgical & Hospital Supplies $3.02M (3.4%) Medicine Ingredients $2.30M (2.6%) Traditional & Herbal $1.33M (1.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Angola in the RBI overseas direct investment dataset (2011–2026).